Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer.
about
Cell-block procedure in endoscopic ultrasound-guided-fine-needle-aspiration of gastrointestinal solid neoplastic lesionsCIViC databaseKRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancer.KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic AdenocarcinomaRAS isoforms and mutations in cancer at a glanceK-Ras mutation detection in liquid biopsy and tumor tissue as prognostic biomarker in patients with pancreatic cancer: a systematic review with meta-analysis.Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer.Role of endoscopic ultrasound in the molecular diagnosis of pancreatic cancer.Translational research in pancreatic ductal adenocarcinoma: current evidence and future concepts.pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104Survival in ampullary cancer: potential role of different KRAS mutations.Novel Methodology for Rapid Detection of KRAS Mutation Using PNA-LNA Mediated Loop-Mediated Isothermal Amplification.Prognostic significance of K-ras mutations in pancreatic cancer: a meta-analysisDigital PCR Improves Mutation Analysis in Pancreas Fine Needle Aspiration Biopsy Specimens.Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing: Implications for Surgical ManagementRAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies.EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104.Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer.Genomic characterization of patient-derived xenograft models established from fine needle aspirate biopsies of a primary pancreatic ductal adenocarcinoma and from patient-matched metastatic sitesStudy of Clinical Survival and Gene Expression in a Sample of Pancreatic Ductal Adenocarcinoma by Parsimony Phylogenetic Analysis.Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypes.Biomarkers for pancreatic cancer: recent achievements in proteomics and genomics through classical and multivariate statistical methods.Endoscopic ultrasound guided fine needle aspiration and useful ancillary methods.KRAS, BRAF, and PIK3CA mutations, and patient prognosis in 126 pancreatic cancers: pyrosequencing technology and literature review.KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma.Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations.Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer.Expression of the scaffold connector enhancer of kinase suppressor of Ras 1 (CNKSR1) is correlated with clinical outcome in pancreatic cancer.Additional K-ras mutation analysis and Plectin-1 staining improve the diagnostic accuracy of pancreatic solid mass in EUS-guided fine needle aspiration.Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer.Reviewing the Utility of EUS FNA to Advance Precision Medicine in Pancreatic Cancer.Utility of Endoscopic Ultrasound-Guided Fine-Needle Aspiration for Preclinical Evaluation of Therapies in Cancer.The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.K-ras mutation analysis of residual liquid-based cytology specimens from endoscopic ultrasound-guided fine needle aspiration improves cell block diagnosis of pancreatic ductal adenocarcinoma.
P2860
Q26795780-8F95B601-EAC1-4630-8D66-4C1215E55A6BQ27612411-2B5D56C3-559F-40B5-881F-6F0AE6E4915EQ27852101-1DCCBFAA-460E-414B-A138-107D1BEBDFE0Q27853365-2B83126C-DECC-488A-BCB4-1293A77A7AFCQ28070394-4C1DC4CE-DBD8-4EA0-A4D7-FC09A0B33BBAQ30250097-8EAC92AD-7E43-46A9-9A1B-0B13C43E1373Q30313606-529DDD1B-B51B-4D79-8224-FE4B0121A1BDQ34067856-A794A718-9EE6-4F81-9E5D-E6269B276BB7Q34067863-3369745D-E1AD-4013-B55D-6A95C4C1C628Q34123654-EF3B3B5F-1666-4076-9F0E-E2CF66090228Q35673204-B39E5EF0-6DD5-4CA5-8F77-62536609743DQ35964856-F77075AD-D05C-4AA9-9E86-F16DE65A35A5Q36018926-4865B9A0-91A4-4971-98A0-FB5DA16EFE29Q36261430-B631B99D-F7E8-4AB9-A4E1-9CA242C8493BQ36326886-70F1481D-5656-405E-B198-CF47E7C58BB7Q36398735-9D185FAE-4EA1-4E59-A63F-788F671986C3Q36594155-26EC77FD-9027-46BB-992D-0499D68F0E49Q37061376-1B54CE30-84C0-41FC-A120-35D5D47060F1Q37086209-2EEB014F-4293-4406-BAB6-73197AF8A1E7Q37141896-4B75686F-96D8-44DA-A3FC-2D7A2BEB9CF2Q37618295-131804A1-B4EA-44D7-8070-FE0AB21810BCQ38259536-DE7F6CB1-709C-4B01-837C-EED2A1C24CA7Q38262111-C26197EC-9C8D-4CDC-A941-06D82ACD7AECQ38755270-FD7DD0CA-3106-4089-9552-4ACB2421556AQ38986151-938BC00B-EBF8-4605-9925-A7186FBAF41AQ40136040-0735B9C8-053C-4BBB-A24D-BDF1C77A3BFFQ40225193-0D818BB1-A94B-48FC-8956-EC4471E8C723Q41095719-04EF5A6D-5EC7-486C-8836-49816C3AFFBEQ42257583-7951DB8B-38F7-4CAE-8233-8662FD006EC1Q45901388-3C1EC771-3C41-4EB1-B079-9ED30AC1E4E7Q49576059-43C4524F-7E3A-4578-BE09-017B1425B2A0Q50097678-D8684BA1-8B19-467C-B797-6374D3B7893AQ50134163-496FEC89-2C63-4500-8DCC-CA4EF3080937Q55359696-9DB2125D-1BF1-4DCA-B9B8-14F7A91522F3
P2860
Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Prognostic value of K-ras muta ...... nresectable pancreatic cancer.
@ast
Prognostic value of K-ras muta ...... nresectable pancreatic cancer.
@en
Prognostic value of K-ras muta ...... nresectable pancreatic cancer.
@nl
type
label
Prognostic value of K-ras muta ...... nresectable pancreatic cancer.
@ast
Prognostic value of K-ras muta ...... nresectable pancreatic cancer.
@en
Prognostic value of K-ras muta ...... nresectable pancreatic cancer.
@nl
prefLabel
Prognostic value of K-ras muta ...... nresectable pancreatic cancer.
@ast
Prognostic value of K-ras muta ...... nresectable pancreatic cancer.
@en
Prognostic value of K-ras muta ...... nresectable pancreatic cancer.
@nl
P2093
P3181
P1476
Prognostic value of K-ras muta ...... nresectable pancreatic cancer.
@en
P2093
Akira Sawaki
Hiroshi Imaoka
Kazuhide Higuchi
Kazuo Hara
Kenji Yamao
Masahiro Tajika
Nobumasa Mizuno
Shinya Kondo
Susumu Hijioka
Takeshi Ogura
P3181
P356
10.1007/S00535-012-0664-2
P577
2013-05-01T00:00:00Z